A recent press release reports, “Veeva Systems and Crossix Solutions today announced that they have entered into a definitive agreement for Veeva to acquire Crossix, the leader in privacy-safe patient data and analytics. Crossix will operate as an independent business unit under its current brand led by Crossix CEO Asaf Evenhaim. Trusted by more than 200 pharmaceutical brands, Crossix delivers privacy-safe U.S. patient data and a best-in-class analytics platform to help maximize media and marketing effectiveness. ‘Crossix has been the pioneer in patient data, privacy, and analytics,’ said Veeva founder and CEO Peter Gassner. ‘As we look toward the future of a more patient-centric healthcare system, Asaf and I are excited to join forces to help the industry deliver better patient outcomes’.”
The release goes on, “The Crossix analytics platform provides technology that connects health and non-health data for more than 300 million U.S. patients to drive greater marketing effectiveness. Data includes Rx, OTC, clinical, claims, consumer, hospital, media data, and more – all of which are protected by best-in-class privacy safeguards. ‘Veeva’s acquisition of Crossix is great for our customers and employees. It allows Crossix to join a proven technology leader and advance our solutions for the industry,’ said Mr. Evenhaim. ‘Most importantly, our companies share a commitment to innovation and have a common way of working that values integrity, long-term thinking, and customer success’.”
Read more at Business Wire.
Image used under license from Shutterstock.com